USPTO serial 79280862
OXY GENE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 16, 2021
- Examiner
- BARAHONA, BYRON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OXY GENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
B-6041 Gosselies, BE
B-6041 Gosselies, BE
B-6041 Gosselies, BE
F-54340 POMPEY, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Monte L. Falcoff/Jessica S. Sachs
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents | ACTIVE | — |
| 042 | Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HENOGEN
- Other trademarks owned by HENOGEN
- Other trademarks owned by HENOGEN
- Other trademarks owned by NOVASEP PROCESS
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named OXY GENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 4, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 23, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 3, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 3, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 16, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 16, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 31, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 31, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 23, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 11, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 11, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2021 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jul 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 13, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2021 | ALIE | ASSIGNED TO LIE | — |
| May 25, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| May 10, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 6, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 3, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 26, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jan 26, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jan 26, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jan 19, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 19, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 19, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 19, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Oct 26, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 26, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 20, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 20, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 14, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 14, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 14, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 11, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 10, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 12, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |